The Role of Dietary Carbohydrates in Gestational Diabetes
Metadatos
Afficher la notice complèteAuteur
Mustad, Vikkie A.; Huynh, Dieu T. T.; López-Pedrosa, José M.; Campoy Folgoso, Cristina; Rueda Valdivia, RicardoEditorial
MDPI
Materia
Gestational diabetes mellitus (GDM) Dietary carbohydrates Diabetes-specific formula Diabetes-specific formula
Date
2020-01-31Referencia bibliográfica
Mustad, V. A., Huynh, D. T., López-Pedrosa, J. M., Campoy, C., & Rueda, R. (2020). The Role of Dietary Carbohydrates in Gestational Diabetes. Nutrients, 12(2), 385.
Résumé
Gestational diabetes (GDM) is hyperglycemia that is recognized for the first time during
pregnancy. GDM is associated with a wide range of short- and long-term adverse health consequences
for both mother and offspring. It is a complex disease with a multifactorial etiology, with disturbances
in glucose, lipid, inflammation and gut microbiota. Consequently, its management is complex,
requiring patients to self-manage their diet, lifestyle and self-care behaviors in combination with use
of insulin. In addition to nutritional recommendations for all pregnant women, special attention
to dietary carbohydrate (CHO) amount and type on glucose levels is especially important in GDM.
Dietary CHO are diverse, ranging from simple sugars to longer-chain oligo- and poly- saccharides
which have diverse effects on blood glucose, microbial fermentation and bowel function. Studies
have established that dietary CHO amount and type can impact maternal glucose and nutritional
recommendations advise women with GDM to limit total intake or choose complex and low glycemic
CHO. However, robust maternal and infant benefits are not consistently shown. Novel approaches
which help women with GDM adhere to dietary recommendations such as diabetes-specific meal
replacements (which provide a defined and complete nutritional composition with slowly-digested
CHO) and continuous glucose monitors (which provide unlimited monitoring of maternal glycemic
fluctuations) have shown benefits on both maternal and neonatal outcomes. Continued research is
needed to understand and develop tools to facilitate patient adherence to treatment goals, individualize
interventions and improve outcomes.